Hong Sub Lee

631 total citations
63 papers, 430 citations indexed

About

Hong Sub Lee is a scholar working on Surgery, Oncology and Epidemiology. According to data from OpenAlex, Hong Sub Lee has authored 63 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Surgery, 17 papers in Oncology and 17 papers in Epidemiology. Recurrent topics in Hong Sub Lee's work include Gastrointestinal motility and disorders (11 papers), Inflammatory Bowel Disease (7 papers) and Eosinophilic Esophagitis (6 papers). Hong Sub Lee is often cited by papers focused on Gastrointestinal motility and disorders (11 papers), Inflammatory Bowel Disease (7 papers) and Eosinophilic Esophagitis (6 papers). Hong Sub Lee collaborates with scholars based in South Korea, United States and Puerto Rico. Hong Sub Lee's co-authors include Kwang Jae Lee, Hye‐Kyung Jung, Jeong‐Hyeon Cho, Young Bae Kim, Jeong‐Ho Kim, Seung Hee Lee, Dong‐Kyu Kim, Mi‐Yeong Kim, Young‐Sang Jung and Young‐Soo Hong and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Medicine.

In The Last Decade

Hong Sub Lee

54 papers receiving 415 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hong Sub Lee South Korea 12 121 117 114 74 73 63 430
Kevin P. Collier United States 3 117 1.0× 82 0.7× 155 1.4× 29 0.4× 49 0.7× 5 507
Cornelis Bhw Lamers Netherlands 6 140 1.2× 69 0.6× 197 1.7× 52 0.7× 49 0.7× 6 549
Natalia Lajczak Ireland 9 162 1.3× 73 0.6× 318 2.8× 164 2.2× 92 1.3× 13 583
Laurie Alston Canada 11 117 1.0× 31 0.3× 249 2.2× 79 1.1× 70 1.0× 17 574
Philip J. Goddard United States 8 175 1.4× 74 0.6× 109 1.0× 35 0.5× 56 0.8× 13 404
Andreas Blesl Austria 10 76 0.6× 44 0.4× 185 1.6× 36 0.5× 133 1.8× 26 423
Zhipeng Tang China 14 83 0.7× 53 0.5× 245 2.1× 53 0.7× 125 1.7× 31 586
Suzy Huijghebaert Belgium 11 98 0.8× 69 0.6× 106 0.9× 126 1.7× 27 0.4× 19 345
Maggie Ham United States 10 198 1.6× 66 0.6× 85 0.7× 22 0.3× 141 1.9× 13 566
Reetta Holma Finland 12 109 0.9× 72 0.6× 327 2.9× 88 1.2× 72 1.0× 16 574

Countries citing papers authored by Hong Sub Lee

Since Specialization
Citations

This map shows the geographic impact of Hong Sub Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong Sub Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong Sub Lee more than expected).

Fields of papers citing papers by Hong Sub Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hong Sub Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong Sub Lee. The network helps show where Hong Sub Lee may publish in the future.

Co-authorship network of co-authors of Hong Sub Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Hong Sub Lee. A scholar is included among the top collaborators of Hong Sub Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hong Sub Lee. Hong Sub Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Min Cheol, et al.. (2025). Treatment of Irritable Bowel Syndrome with Predominant Diarrhea. Korean Journal of Gastroenterology. 85(2). 105–109.
2.
Kim, Eun Ran, Min‐Ji Kim, Seong‐Jung Kim, et al.. (2025). Long-Term Outcomes after the Complete Resection of Rectal Neuroendocrine Tumors: A Multicenter Cohort Study. Gut and Liver. 20(2). 275–282.
3.
4.
Park, Ji Hwan, Hong Sub Lee, Seung Jung Yu, et al.. (2024). Differences in Prevalence and Psychosocial Characteristics of Irritable Bowel Syndrome According to Rome III and Rome IV Criteria in Medical and Nursing Students. Journal of Neurogastroenterology and Motility. 30(4). 491–500.
5.
Choi, Eun Jeong, et al.. (2024). An exploratory multi-omics study reveals distinct molecular signatures of ulcerative colitis and Crohn's disease and their correlation with disease activity. Journal of Pharmaceutical and Biomedical Analysis. 255. 116652–116652. 1 indexed citations
6.
Koo, Hoon Sup, Hong Sub Lee, Ju Kim, et al.. (2023). Survey-Based Analysis of the Clinical Treatment Status of Irritable Bowel Syndrome in Korea. Journal of Korean Medical Science. 38(16). e126–e126. 1 indexed citations
8.
Park, Yong Eun, Seung Bum Lee, Hong Sub Lee, et al.. (2023). Outcomes according to treatment modalities as a bridge to curative surgery for malignant obstruction of the proximal colon: stent versus stoma. The Korean Journal of Internal Medicine. 38(2). 186–194.
9.
Koh, Seong‐Joon, Sung Noh Hong, Soo Kyung Park, et al.. (2022). Korean clinical practice guidelines on biologics for moderate to severe Crohn’s disease. Intestinal Research. 21(1). 43–60. 27 indexed citations
10.
Jee, Sam Ryong, Sang Heon Lee, Ji Hyun Kim, et al.. (2022). Comparison of the efficacy and complications of endoscopic incisional therapy and balloon dilatation for benign esophageal strictures. SHILAP Revista de lepidopterología. 37(4). 291–298.
11.
Yu, Seung Jung, Eun Jeong Choi, Jong Hyuk Kim, et al.. (2022). Role of multidetector computed tomography in patients with acute infectious colitis. World Journal of Clinical Cases. 10(12). 3686–3697. 2 indexed citations
13.
Kang, Sang‐Hyun, et al.. (2021). Comparison between oxaliplatin therapy and capecitabine monotherapy for high-risk stage II – III elderly patients with colon cancer. Asian Journal of Surgery. 45(1). 448–455. 4 indexed citations
14.
Shin, Dongseong, et al.. (2019). <p>Pharmacokinetics and tolerability of IDP-73152 mesylate after a single oral administration under fasted and fed conditions in healthy volunteers</p>. Drug Design Development and Therapy. Volume 13. 2483–2490. 2 indexed citations
15.
Lee, Hong Sub & Kwang Jae Lee. (2019). Immunoglobulin G4-related immune responses to common food antigens in patients with ulcerative colitis and Crohn’s disease. The Turkish Journal of Gastroenterology. 30(5). 408–414. 10 indexed citations
16.
Lee, Hong Sub, et al.. (2017). Bacterial Ulcerative Esophagitis in an Immunocompetent Patient. Case Reports in Gastroenterology. 11(1). 162–167. 3 indexed citations
17.
Han, Jae‐Ho, et al.. (2016). Clinical outcomes of endoscopic surveillance for gastric ulcers in populations with a high prevalence of gastric cancer. The Turkish Journal of Gastroenterology. 27(5). 421–427. 6 indexed citations
18.
Kim, Sun Mi, Hong Sub Lee, Yun Jung Jung, et al.. (2010). Entecavir-induced Tubulointerstitial Nephritis. Kidney Research and Clinical Practice. 29(4). 504–508. 2 indexed citations
19.
Lee, Hong Sub, Jung Su Ryu, Young‐Soo Hong, et al.. (2006). Apoptosis induced by ID6105, a new anthracycline (11-hydroxyaclacinomycin X, Hyrubicin), and its anti-tumor effects on experimental tumor models. Cancer Chemotherapy and Pharmacology. 60(2). 197–201. 6 indexed citations
20.
Kwon, Oh‐Seung, Young‐Soo Hong, Jung Joon Lee, et al.. (2005). Pharmacokinetics of 11-hydroxyaclacinomycin X (ID-6105), a novel anthracycline, after i.v. bolus multiple administration in rats. Archives of Pharmacal Research. 28(4). 476–482. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026